(VIANEWS) - Harmony Biosciences Holdings (HRMY), Agree Realty Corporation (ADC), Edwards Lifesciences (EW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Harmony Biosciences Holdings (HRMY)
61.4% sales growth and 24.39% return on equity
Harmony Biosciences Holdings, Inc., is a pharmaceutical company at the commercial stage that develops and markets therapies for rare neurological conditions.
Harmony Biosciences Holdings's sales growth this year is expected to be 91.3% and 53.2% for next year.
Year-on-year quarterly revenue growth grew by 62%, now sitting on 305.44M for the twelve trailing months.
Volume
Today's last reported volume for Harmony Biosciences Holdings is 408616 which is 8.09% above its average volume of 378023.
Harmony Biosciences Holdings's sales growth for the next quarter is 61.4%. The company's growth estimates for the current quarter and the next is 40% and 161.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.39%.
Volatility
Harmony Biosciences Holdings's last day, last week, and last month's current intraday variation average was 0.79%, 3.12%, and 2.95%, respectively.
Harmony Biosciences Holdings's highest amplitude of average volatility was 4.34% (day), 4.92% (last week), and 5.68% (last month), respectively.
Harmony Biosciences Holdings's Stock Yearly Top and Bottom Value
Harmony Biosciences Holdings's stock is valued at $49.66 at 16:22 EST, under its 52-week high of $50.45 and way above its 52-week low of $25.09.
Harmony Biosciences Holdings's Moving Average
Harmony Biosciences Holdings's worth is way above its 50-day moving average of $39.43 and way above its 200-day moving average of $36.60.2. Agree Realty Corporation (ADC)
21.6% sales growth and 4.04% return on equity
Agree Realty Corporation, a publicly traded trust for real estate investments, focuses primarily on the acquisition and development properties that are net leased to top-tier retail tenants.
Agree Realty Corporation's sales growth this year is expected to be 21% and 17.8% for next year.
Year-on-year quarterly revenue growth grew by 37.2%, now sitting on 319.33M for the twelve trailing months.
Volume
Today's last reported volume for Agree Realty Corporation is 375874 which is 31.44% below its average volume of 548317.
Agree Realty Corporation's sales growth for the next quarter is 21.6%. The company's growth estimates for the ongoing quarter and the next is a negative 6.2% and 32.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.04%.
Volatility
Agree Realty Corporation's last day, last week, and last month's current intraday variation average was 1.30%, 0.66%, and 0.98%, respectively.
Agree Realty Corporation's highest amplitude of average volatility was 1.52% (day), 1.58% (last week), and 2.06% (last month), respectively.
Agree Realty Corporation's Stock Yearly Top and Bottom Value
Agree Realty Corporation's stock is valued at $65.44 at 16:22 EST, way under its 52-week high of $75.95 and higher than its 52-week low of $61.62.
Agree Realty Corporation's Moving Average
Agree Realty Corporation's value is above its 50-day moving average of $64.22 and under its 200-day moving average of $69.26.3. Edwards Lifesciences (EW)
11.8% sales growth and 28.88% return on equity
Edwards Lifesciences Corporation offers products and technology for critical care, surgical monitoring and structural heart disease in the United States as well as internationally.
Edwards Lifesciences's sales growth this year is expected to be 19.8% and 10.7% for next year.
Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 5.23B for the twelve trailing months.
Volume
Today's last reported volume for Edwards Lifesciences is 2748470 which is 4.61% above its average volume of 2627160.
Edwards Lifesciences's sales growth for the next quarter is 11.8%. The company's growth estimates for the current quarter and the next is 10% and 11.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.88%.
Volatility
Edwards Lifesciences's last day, last week, and last month's current intraday variation average was 2.17%, 2.91%, and 1.82%, respectively.
Edwards Lifesciences's highest amplitude of average volatility was 3.45% (day), 3.46% (last week), and 2.98% (last month), respectively.
Edwards Lifesciences's Stock Yearly Top and Bottom Value
Edwards Lifesciences's stock is valued at $118.00 at 16:22 EST, way under its 52-week high of $131.73 and way higher than its 52-week low of $81.20.
Edwards Lifesciences's Moving Average
Edwards Lifesciences's worth is above its 50-day moving average of $109.99 and above its 200-day moving average of $113.46.4. Middlesex Water Company (MSEX)
11.7% sales growth and 10.18% return on equity
Middlesex Water Company operates and owns regulated wastewater and water utilities.
Middlesex Water Company's sales growth this year is expected to be 17.2% and 4.7% for next year.
Year-on-year quarterly revenue growth declined by 1.7%, now sitting on 143.14M for the twelve trailing months.
Volume
Today's last reported volume for Middlesex Water Company is 55878 which is 60.05% below its average volume of 139875.
Middlesex Water Company's sales growth for the next quarter is 11.7%. The company's growth estimates for the current quarter and the next is 33.3% and 14.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.18%.
Volatility
Middlesex Water Company's last day, last week, and last month's current intraday variation average was 2.81%, 1.76%, and 1.41%, respectively.
Middlesex Water Company's highest amplitude of average volatility was 3.80% (day), 2.73% (last week), and 2.82% (last month), respectively.
Middlesex Water Company's Stock Yearly Top and Bottom Value
Middlesex Water Company's stock is valued at $103.17 at 16:22 EST, way under its 52-week high of $121.43 and way higher than its 52-week low of $76.03.
Middlesex Water Company's Moving Average
Middlesex Water Company's value is above its 50-day moving average of $100.99 and above its 200-day moving average of $101.79.5. Integra LifeSciences Holdings Corporation (IART)
9.1% sales growth and 14.29% return on equity
Integra LifeSciences Holdings Corporation designs, produces, and markets surgical instruments and implants for neurosurgery and other general surgeries.
Integra LifeSciences Holdings Corporation's sales growth this year is anticipated to be 12.3% and 5.8% for next year.
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 1.53B for the twelve trailing months.
Volume
Today's last reported volume for Integra LifeSciences Holdings Corporation is 598207 which is 44.39% above its average volume of 414278.
Integra LifeSciences Holdings Corporation's sales growth for the next quarter is 9.1%. The company's growth estimates for the current quarter and the next is a negative 1.2% and 10.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.29%.
Volatility
Integra LifeSciences Holdings Corporation's last day, last week, and last month's current intraday variation average was 0.06%, 0.57%, and 1.03%, respectively.
Integra LifeSciences Holdings Corporation's highest amplitude of average volatility was 3.42% (day), 2.47% (last week), and 2.79% (last month), respectively.
Integra LifeSciences Holdings Corporation's Stock Yearly Top and Bottom Value
Integra LifeSciences Holdings Corporation's stock is valued at $65.44 at 16:22 EST, way under its 52-week high of $77.40 and higher than its 52-week low of $61.50.
Integra LifeSciences Holdings Corporation's Moving Average
Integra LifeSciences Holdings Corporation's worth is below its 50-day moving average of $66.10 and below its 200-day moving average of $68.36.6. Qorvo (QRVO)
7% sales growth and 24.18% return on equity
Qorvo, Inc. designs and markets technologies for wired and wireless connectivity around the world.
Qorvo's sales growth this year is expected to be 15% and 9.3% for next year.
Year-on-year quarterly revenue growth grew by 18.4%, now sitting on 4.53B for the twelve trailing months.
Volume
Today's last reported volume for Qorvo is 765513 which is 46.37% below its average volume of 1427510.
Qorvo's sales growth is a negative 0% for the ongoing quarter and 7% for the next. The company's growth estimates for the current quarter and the next is a negative 10.4% and 4.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.18%.
Volatility
Qorvo's last day, last week, and last month's current intraday variation average was 3.50%, 2.65%, and 2.17%, respectively.
Qorvo's highest amplitude of average volatility was 3.91% (day), 3.55% (last week), and 3.33% (last month), respectively.
Qorvo's Stock Yearly Top and Bottom Value
Qorvo's stock is valued at $124.53 at 16:22 EST, way under its 52-week high of $201.68 and above its 52-week low of $117.03.
Qorvo's Moving Average
Qorvo's value is below its 50-day moving average of $132.62 and way under its 200-day moving average of $162.53.Previous days news about Qorvo(QRVO)
- According to Bloomberg Quint on Monday, 28 March, "Shares of some Apple suppliers also fell, with Qorvo Inc. down 2.4% in premarket and Varta AG declining 3.4% in Frankfurt after the Nikkei report."
7. Paychex (PAYX)
5.8% sales growth and 42.57% return on equity
Paychex, Inc. offers integrated solutions in human capital management for HR, payroll, benefits, insurance, and other services to small and medium-sized companies throughout the United States.
Paychex's sales growth this year is expected to be 10.5% and 6.6% for next year.
Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 4.33B for the twelve trailing months.
Volume
Today's last reported volume for Paychex is 1972700 which is 2.58% above its average volume of 1923070.
Paychex's sales growth is a negative 0% for the present quarter and 5.8% for the next. The company's growth estimates for the current quarter and the next is 8.3% and 8.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.57%.
Volatility
Paychex's last day, last week, and last month's current intraday variation average was 1.33%, 1.80%, and 1.51%, respectively.
Paychex's highest amplitude of average volatility was 3.32% (day), 3.23% (last week), and 2.64% (last month), respectively.
Paychex's Stock Yearly Top and Bottom Value
Paychex's stock is valued at $137.19 at 16:22 EST, below its 52-week high of $138.97 and way above its 52-week low of $92.74.
Paychex's Moving Average
Paychex's value is way above its 50-day moving average of $120.63 and way higher than its 200-day moving average of $118.21.Previous days news about Paychex(PAYX)
- Paychex stock jumps toward 3-month high after profit and revenue beats, raised outlook. According to MarketWatch on Wednesday, 30 March, "Shares of Paychex Inc. surged 1.9% toward a three-month high in premarket trading Wednesday, after the human resources outsourcing services company reported fiscal third-quarter profit and revenue that rose above expectations, and boosted its full-year growth outlook, as record new sales revenue was coupled with high levels of client retention. "
- According to The Wall Street Journal on Saturday, 26 March, "We continue to get a decent amount of volume," said Frank Fiorille, vice president of payroll processor Paychex Inc., which has processed more than $7 billion in requests for the credit. ", "It can be close to a hundred a day." The average credit for Paychex customers is $170,000, he said."